When SUV Matters: FDG PET/CT at Baseline Correlates with Survival in Soft Tissue and Ewing Sarcoma.
Ruben I HackAnton Sebastian BeckerBeata Bode-LesniewskaG Ulrich ExnerDaniel A MüllerDaniela A FerraroGeoffrey I WarnockIrene Andrea BurgerChristian BritschgiPublished in: Life (Basel, Switzerland) (2021)
Our analysis shows that the outcome of soft tissue, bone and Ewing sarcomas is associated with different PET/CT metrics. We could not confirm the previously suggested superiority of volume-based metrics in soft tissue sarcomas, for which we found SUVmax to remain the best prognostic factor. However, bone sarcomas should probably be evaluated with tumor volume rather than FDG PET activity.